Systematic Reviews
Copyright ©The Author(s) 2022.
World J Orthop. Sep 18, 2022; 13(9): 825-836
Published online Sep 18, 2022. doi: 10.5312/wjo.v13.i9.825
Table 1 Included randomized controlled trials with characteristics
First author (last name)
Journal
Year
Comparison
Patients enrolled
Patients lost to follow up
Final study, n
JADAD score
Power analysis
KimJ Orthop Trauma2015ORPO (LCP) vs MIPO724683Yes
EsmailiejahTrauma Mon2015ORPO (DCP) vs MIPO683653No
FanOrthopedics2015ORPO (LCP) vs IMN600602Yes
HadhoudMenoufia Medical Journal2015ORPO (LCP) vs MIPO300302No
WaliStrategies Trauma Limb Reconstr2014ORPO (DCP) vs IMN500502No
BenegasJ Shoulder Elbow Surg2014MIPO vs IMN411403Yes
LianOrthopedics2013MIPO vs IMN569473No
LiJ Shoulder Elbow Surg2011ORPO (LCP) vs IMN505453Yes
IqbalAnnals of King Edward Medical University2011ORPO (DCP) vs IMN400403No
SingisettiInt Orthop2010ORPO (DCP) vs IMN459361No
PuttiJ Orthop Surg (Hong Kong)2009ORPO (DCP) vs IMN340342No
ChangulaniInt Orthop2007ORPO (DCP) vs IMN472453No
KesemenliActa Orthop Traumatol Turc2003ORPO (DCP) vs IMN600602No
McCormackJ Bone Joint Surg (Br)2000ORPO (DCP) vs IMN443412No
ChapmanJ Orthop Trauma2000ORPO (DCP) vs IMN895843No
Table 2 Summary characteristics of included randomized controlled trials
Characteristic
No.
% or range
Initial sample size, mean No.52.4(30-89)
Lost to follow up, mean No.2.7(0-9)
Final sample size, mean No.49.7(30-84)
Power analysis426.7%
Comparison groups
ORPO (DCP) vs IMN853.3%
ORPO (LCP) vs IMN213.3%
MIPO vs IMN213.3%
ORPO (LCP) vs MIPO213.3%
ORPO (DCP) vs MIPO16.7%
Outcome assessed
Delayed union/nonunion15100.0%
Iatrogenic radial nerve palsy15100.0%
Infection1493.3%
Secondary surgeries1173.3%
Shoulder impingement 1066.7%
Malunion746.7%
Elbow stiffness426.7%
Table 3 Fragility index values for each outcome for included randomized controlled trials
First author (last name)
Comparison
Delayed union/ Nonunion
Iatrogenic radial nerve palsy
Infection
Malunion
Shoulder Impingement
Elbow Stiffness
All complications
Secondary surgeries
KimORPO (LCP) vs MIPO0000NANA00
EsmailiejahORPO (DCP) vs MIPO0000NANA00
FanORPO (LCP) vs IMN00NANANANA0NA
HadhoudORPO (LCP) vs MIPO000NANANA0NA
WaliORPO (DCP) vs IMN000NA0000
BenegasMIPO vs IMN00000NA00
LianMIPO vs IMN0000104NA
LiORPO (LCP) vs IMN0002NANA0NA
IqbalORPO (DCP) vs IMN000NA0NA00
SingisettiORPO (DCP) vs IMN000NA0000
PuttiORPO (DCP) vs IMN000NA0NA00
ChangulaniORPO (DCP) vs IMN000NA1NA00
KesemenliORPO (DCP) vs IMN010NA0NA00
McCormackORPO (DCP) vs IMN00002NA61
ChapmanORPO (DCP) vs IMN00002100
Table 4 Summary of outcomes with reported differences between groups
Continuous variable
Superior treatment
Inferior treatment
First author (last name)
Time to unionIMNORPOChangulani
Time to unionIMNORPOFan
Operative timeIMNORPOFan
Operative timeIMNORPOWali
Operative timeMIPOIMNLian
Operative timeMIPOORPOHadhoud
Intraoperative blood loss IMNORPOFan
Intraoperative blood lossIMNORPOWali
Intraoperative blood lossMIPOIMNLian
Hospital stayIMNORPOFan
Hospital stayIMNORPOWali
Constant scoresMIPOIMNLi
Rodriguez-Merchan criteriaDCPIMNSingisetti
Shoulder ROMMIPOIMNLi
Shoulder ROMDCPIMNChapman
Elbow ROMIMNDCPChapman